Skip to main content
. 2022 Mar 31;5(3):e224427. doi: 10.1001/jamanetworkopen.2022.4427

Figure 1. Study Route.

Figure 1.

The control group received the traditional model of follow-up; the intervention group received the electronic patient-reported outcome (ePRO) model, follow-up monitoring, and consultation via the ePRO application (app). irAE indicates immune-related adverse effect; serious irAEs include grades 3 to 4.